THYROCARE TECHNOLOGIES
Back to Balance Sheet
|
THYROCARE TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹2.26 Cr | ₹0.62 Cr | ₹1.61 Cr | ₹1.61 Cr | ₹51 Cr |
What is the latest Contingent Liabilities ratio of THYROCARE TECHNOLOGIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹2.26 Cr |
| Mar2024 | ₹0.62 Cr |
| Mar2023 | ₹1.61 Cr |
| Mar2022 | ₹1.61 Cr |
| Mar2021 | ₹51 Cr |
How is Contingent Liabilities of THYROCARE TECHNOLOGIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.26 Cr | 264.52 | |
| Mar2024 | ₹0.62 Cr | -61.49 | |
| Mar2023 | ₹1.61 Cr | 0.00 | |
| Mar2022 | ₹1.61 Cr | -96.83 | |
| Mar2021 | ₹51 Cr | - | |
Compare Contingent Liabilities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹7,308.9 Cr | 2.3% | 6% | 47% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹103,401.0 Cr | -0.1% | -2.2% | -7.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹102,508.0 Cr | 0.7% | -0.7% | -2.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹69,074.9 Cr | 3.4% | 1.9% | 24.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹39,212.8 Cr | 3.3% | -1.9% | 51.9% | Stock Analytics | |
| GLOBAL HEALTH | ₹32,702.4 Cr | 5.4% | 0.5% | 10.5% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | 2.3% |
6% |
47% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses